Literature DB >> 24903787

Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.

V Amlabu1, C Mulligan2, N Jele2, A Evans1, D Gray2, H J Zar2, H McIlleron1, P Smith1.   

Abstract

The Arkansas colorimetric method monitors adherence to isoniazid (INH) by the detection of INH metabolites in urine. Urine samples 4 h after INH administration in 31 human immunodeficiency virus infected children receiving daily or thrice weekly INH preventive therapy were Arkansas test-positive for 29/31 (94%), while acetylisoniazid (AcINH) was detected in 30/31 (97%) using mass spectrometry. At 24, 48 and 72 h, only 78%, 23% and 0 samples, respectively, were Arkansas-positive, while INH or AcINH was detected in respectively 94%, 69% and 33%. The Arkansas test reliably predicted INH ingestion at a clinic visit 4 h after morning doses, but did not perform well at 24 h.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903787      PMCID: PMC4229494          DOI: 10.5588/ijtld.13.0730

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Urine testing to monitor adherence to TB preventive therapy.

Authors:  Sharon Perry; Melbourne F Hovell; Elaine Blumberg; Jill Berg; Alicia Vera; Carol Sipan; Norma Kelley; Kathleen Moser; Antonino Catanzaro; Larry Friedman
Journal:  J Clin Epidemiol       Date:  2002-03       Impact factor: 6.437

2.  Evaluation of the Arkansas method of urine testing for isoniazid in South Africa.

Authors:  Y Hanifa; K Mngadi; J Lewis; K Fielding; G Churchyard; A D Grant
Journal:  Int J Tuberc Lung Dis       Date:  2007-11       Impact factor: 2.373

3.  Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine.

Authors:  J O Kilburn; R E Beam; H L David; E Sanchez; R F Corpe; W Dunn
Journal:  Am Rev Respir Dis       Date:  1972-12

4.  Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.

Authors:  Renata L Guerra; Marcus B Conde; Anne Efron; Carla Loredo; Gisele Bastos; Richard E Chaisson; Jonathan E Golub
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

5.  Follow-up of compliance with tuberculosis treatment in children: monitoring by urine tests.

Authors:  Ayşe Palanduz; Derya Gultekin; Nimet Kayaalp
Journal:  Pediatr Pulmonol       Date:  2003-07

6.  Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  Testing for isoniazid. An evaluation of the Arkansas method.

Authors:  D E Schraufnagel; R Stoner; E Whiting; G Snukst-Torbeck; M J Werhane
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

  7 in total
  3 in total

1.  Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia.

Authors:  U Egere; A Sillah; T Togun; S Kandeh; F Cole; A Jallow; A Able-Thomas; M Hoelscher; N Heinrich; P C Hill; B Kampmann
Journal:  Public Health Action       Date:  2016-12-21

2.  High throughput metabolomics-proteomics investigation on metabolic phenotype changes in rats caused by Radix Scrophulariae using ultra-performance liquid chromatography with mass spectrometry.

Authors:  Fang Lu; Ning Zhang; Tao Ye; Hongwei Zhao; Mu Pang; Shu-Min Liu
Journal:  RSC Adv       Date:  2019-06-06       Impact factor: 4.036

3.  Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis.

Authors:  Sylvia M LaCourse; Daniel Leon; Nuttada Panpradist; Barbra A Richardson; Elizabeth Maleche-Obimbo; Jerphason Mecha; Daniel Matemo; Jaclyn N Escudero; John Kinuthia; Barry Lutz; Grace John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2021-01       Impact factor: 2.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.